Amelioration of dextran sulfate sodium-induced colitis in mice by oral administration of β-caryophyllene, a sesquiterpene

Life Sciences

Volumn 80, Issue 10, 2007, Pages 932-939

  Cho, Jae Young ^a   Chang, Hyun Joo ^a   Lee, Sang Kil ^b   Kim, Hyo Jong ^b   Hwang, Jae Kwan ^c   Chun, Hyang Sook ^a  

^a Korea Food Research Institute   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Caryophyllene; Colitis; Dextran sulfate sodium; Interleukin 6; Mice

Indexed keywords

CARYOPHYLLENE; CYTOKINE; DEXTRAN SULFATE; DRINKING WATER; INTERLEUKIN 6; MESSENGER RNA; MYELOPEROXIDASE; SESQUITERPENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; COLITIS; COLON; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME ACTIVITY; HISTOLOGY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN BLOOD LEVEL; SERUM;

ANIMALS; BODY WEIGHT; COLITIS; CYTOKINES; DEXTRAN SULFATE; ENZYME-LINKED IMMUNOSORBENT ASSAY; INDICATORS AND REAGENTS; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED BALB C; ORGAN SIZE; PEROXIDASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SESQUITERPENES;

MUS;

EID: 33846841180     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.11.038     Document Type: Article

References (42)

1. Agarwal R.B., and Rangari V.D. Phytochemical investigation and evaluation of anti-inflammatory and anti-arthritic activities of essential oil of Strobilanthus ixiocephala Benth. Indian Journal of Experimental Biology 41 (2003) 890-894
2. Alma M.H., Mavi A., Yildirim A., Digrak M., and Hirata T. Screening chemical composition and in vitro antioxidant and antimicrobial activities of the essential oils from Origanum syriacum L. growing in Turkey. Biological & Pharmaceutical Bulletin 26 (2003) 1725-1729
3. Axelsson L.G., Landstrom E., and Bylund-Fellenius A.C. Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine. Alimentary Pharmacology and Therapeutics 12 (1998) 925-934
4. Baricevic D., Sosa S., Della Loggia R., Tubaro A., Simonovska B., Krasna A., and Zupancic A. Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid. Journal of Ethnopharmacology 75 (2001) 125-132
5. Bouma G., and Strober W. The immunological and genetic basis of inflammatory bowel disease. Nature Reviews. Immunology 3 (2003) 521-533
6. Carrier J.C., Aghdassi E., Jeejeebhoy K., and Allard J.P. Exacerbation of dextran sulfate sodium-induced colitis by dietary iron supplementation: role of NF-kappa B. International Journal of Colorectal Disease (2005) 1-7
7. Ciancio M.J., Vitiritti L., Dhar A., and Chang E.B. Endotoxin-induced alterations in rat colonic water and electrolyte transport. Gastroenterology 103 (1992) 1437-1443
8. Cooper H.S., Murthy S.N., Shah R.S., and Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Laboratory Investigation 69 (1993) 238-249
9. Cornwell P.A., and Barry B.W. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. Journal of Pharmacy and Pharmacology 46 (1994) 261-269
10. Cuzzocrea S., Ianaro A., Wayman N.S., Mazzon E., Pisano B., Dugo L., Serraino I., Di Paola R., Chatterjee P.K., Di Rosa M., Caputi A.P., and Thiemermann C. The cyclopentenone prostaglandin 15-deoxy-delta(12,14)-PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat. British Journal of Pharmacology 138 (2003) 678-688
11. Di Sabatino A., Morera R., Ciccocioppo R., Cazzola P., Gotti S., Tinozzi F.P., Tinozzi S., and Corazza G.R. Oral butyrate for mildly to moderately active Crohn's disease. Alimentary Pharmacology and Therapeutics 22 (2005) 789-794
12. Dieleman L.A., Ridwan B.U., Tennyson G.S., Beagley K.W., Bucy R.P., and Elson C.O. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107 (1994) 1643-1652
13. Egger B., Bajaj-Elliott M., MacDonald T.T., Inglin R., Eysselein V.E., and Buchler M.W. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 62 (2000) 240-248
14. Erdman S.H., Christensen R.D., Bradley P.P., and Rothstein G. Supply and release of storage neutrophils. A developmental study. Biology of the Neonate 41 (1982) 132-137
15. Esteves I., Souza I.R., Rodrigues M., Cardoso L.G., Santos L.S., Sertie J.A., Perazzo F.F., Lima L.M., Schneedorf J.M., Bastos J.K., and Carvalho J.C. Gastric antiulcer and anti-inflammatory activities of the essential oil from Casearia sylvestris Sw. Journal of Ethnopharmacology 101 (2005) 191-196
16. FEMA. FEMA Database: Beta-Caryophyllene (FEMA No. 2252) (1997), Flavor and Extract Manufacturers Association, Washington, DC 12
17. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115 (1998) 182-205
18. Grisham M.B., and Granger D.N. Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Digestive Diseases and Sciences 33 (1988) 6S-15S
19. Heck J.D., Vollmuth T.A., Cifone M.A., Jagannath D.R., Myhr B., and Curren R.D. An evaluation of food flavoring ingredients in a genetic toxicity screening battery. Toxicologist 9 (1989) 257
20. Hendrickson B.A., Gokhale R., and Cho J.H. Clinical aspects and pathophysiology of inflammatory bowel disease. Clinical Microbiology Reviews 15 (2002) 79-94
21. Ishiguro K., Ando T., Maeda O., Hasegawa M., Kadomatsu K., Ohmiya N., Niwa Y., Xavier R., and Goto H. Paeonol attenuates TNBS-induced colitis by inhibiting NF-κB and STAT1 transactivation. Toxicology and Applied Pharmacology 217 (2006) 35-42
22. Ka M.-H., Choi E.H., Chun H.S., and Lee K.-G. Antioxidative activity of volatile extracts isolated from Angelica tenuissimae roots, peppermint leaves, pine needles, and sweet flag leaves. Journal of Agricultural and Food Chemistry 53 (2005) 4124-4129
23. Kraft S.C., and Kirsner J.B. Immunological apparatus of the gut and inflammatory bowel disease. Gastroenterology 60 (1971) 922-951
24. Kubo I., Chaudhuri S.K., Kubo Y., Sanchez Y., Ogura T., Saito T., Ishikawa H., and Haraguchi H. Cytotoxic and antioxidative sesquiterpenoids from Heterotheca inuloides. Planta Medica 62 (1996) 427-430
25. 50 of eugenol by intratracheal instillation in rats and hamsters. Archives of Toxicology 59 (1986) 78-81
26. Lourens A.C., Reddy D., Baser K.H., Viljoen A.M., and Van Vuuren S.F. In vitro biological activity and essential oil composition of four indigenous South African Helichrysum species. Journal of Ethnopharmacology 95 (2004) 253-258
27. Lovato P., Brender C., Agnholt J., Kelsen J., Kaltoft K., Svejgaard A., Eriksen K.W., Woetmann A., and Odum N. Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease. Journal of Biological Chemistry 278 (2003) 16777-16781
28. Lu J., Wang A., Ansari S., Hershberg R.M., and McKay D.M. Colonic bacterial superantigens evoke an inflammatory response and exaggerate disease in mice recovering from colitis. Gastroenterology 125 (2003) 1785-1795
29. Martin S., Padilla E., Ocete M.A., Galvez J., Jimenez J., and Zarzuelo A. Anti-inflammatory activity of the essential oil of Bupleurum fruticescens. Planta Medica 59 (1993) 533-536
30. Murthy S.N., Cooper H.S., Shim H., Shah R.S., Ibrahim S.A., and Sedergran D.J. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Digestive Diseases and Sciences 38 (1993) 1722-1734
31. Musso A., Dentelli P., Carlino A., Chiusa L., Repici A., Sturm A., Fiocchi C., Rizzetto M., Pegoraro L., Sategna-Guidetti C., and Brizzi M.F. Signal transducers and activators of transcription 3 signaling pathway: an essential mediator of inflammatory bowel disease and other forms of intestinal inflammation. Inflammatory Bowel Diseases 11 (2005) 91-98
32. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., and Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98 (1990) 694-702
33. Olson A.D., DelBuono E.A., Bitar K.N., and Remick D.G. Antiserum to tumor necrosis factor and failure to prevent murine colitis. Journal of Pediatric Gastroenterology and Nutrition 21 (1995) 410-418
34. Opdyke D.L. Monographs on fragrance raw materials. Food and Cosmetics Toxicology 11 (1973) 1011-1081
35. Podolsky D.K. Inflammatory bowel disease (2). New England Journal of Medicine 325 (1991) 1008-1016
36. Rogler G., and Andus T. Cytokines in inflammatory bowel disease. World Journal of Surgery 22 (1998) 382-389
37. Sandborn W.J., and Targan S.R. Biologic therapy of inflammatory bowel disease. Gastroenterology 122 (2002) 1592-1608
38. Singh G., Marimuthu P., de Heluani C.S., and Catalan C.A. Antioxidant and biocidal activities of Carum nigrum (seed) essential oil, oleoresin, and their selected components. Journal of Agricultural and Food Chemistry 54 (2006) 174-181
39. Tambe Y., Tsujiuchi H., Honda G., Ikeshiro Y., and Tanaka S. Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene. Planta Medica 62 (1996) 469-470
40. Tomoyose M., Mitsuyama K., Ishida H., Toyonaga A., and Tanikawa K. Role of interleukin-10 in a murine model of dextran sulfate sodium-induced colitis. Scandinavian Journal of Gastroenterology 33 (1998) 435-440
41. van Meeteren M.E., Meijssen M.A., and Zijlstra F.J. The effect of dexamethasone treatment on murine colitis. Scandinavian Journal of Gastroenterology 35 (2000) 517-521
42. Villegas I., Alarcon de la Lastra C., Orjales A., and La Casa C. A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice. International Immunopharmacology 3 (2003) 1731-1741